US Patent Issued to Alto Neuroscience on Jan. 13 for "Combination therapy for a dopamine agonist" (District Of Columbia Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,374, issued on Jan. 13, was assigned to Alto Neuroscience Inc. (Mountain View, Calif.).

"Combination therapy for a dopamine agonist" was invented by Kathleen E. Clarence-Smith (Washington) and Thomas N. Chase (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application describes a method of reducing emesis caused by a dopamine agonist in a patient with depression who is treated with a dopamine agonist, comprising administering ondansetron in combination with the dopamine agonist."

The patent was filed on June 20, 2025, under Application No. 19/244,143.

*For further information, including images, charts and tables, please visit: http:...